Literature DB >> 3623829

Arthritis in MRL/LPR mice and in collagen II sensitized DBA-1 mice and their use in pharmacology.

C Rordorf, A Pataki, V Nogues, F Schlager, U Feige, M Glatt.   

Abstract

For assessment of anti-arthritic drugs, we used mice of the autoimmune MRL/lpr strain and DBA-1 mice sensitized with collagen type II. Our studies showed that in these two mouse arthritis models, unlike the classical rat adjuvant arthritis, the nonsteroidal antiinflammatory compounds tested were either ineffective or minimally affected a chosen number of humoral parameters and the incidence and severity of arthritis. Interestingly, both arthritis models showed a distinct pharmacological pattern in response to the slow-acting anti-rheumatic drugs, whereas steroids and cyclophosphamide inhibited both arthritic processes. Therefore, these two mouse models are useful for studying the immunopathological events operating in chronic inflammation and could potentially serve the characterization of new antirheumatic drugs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3623829

Source DB:  PubMed          Journal:  Int J Tissue React        ISSN: 0250-0868


  5 in total

1.  Effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis of mice.

Authors:  G W Cannon; S McCall; B C Cole; M M Griffiths; L A Radov; J R Ward
Journal:  Agents Actions       Date:  1990-03

2.  Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice.

Authors:  Y Fujimori; T Nakamura; K Shimizu; T Yamamuro; K Wanaka; S Okamoto; Y Katsuura
Journal:  Agents Actions       Date:  1993-05

3.  Effect of cyclophosphamide on lymphokine production in MRL/lpr.Yaa mice.

Authors:  H Kamada; Y Takaoka; K Kitagaki; H Nagai
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

Review 4.  Animal models for osteoarthritis: processes, problems and prospects.

Authors:  K P Pritzker
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

5.  Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice.

Authors:  L G Ratkay; R K Chowdhary; H C Neyndorff; J Tonzetich; J D Waterfield; J G Levy
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.